Does LAPATINIB Cause Malignant neoplasm progression? 173 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 173 reports of Malignant neoplasm progression have been filed in association with LAPATINIB. This represents 8.7% of all adverse event reports for LAPATINIB.
173
Reports of Malignant neoplasm progression with LAPATINIB
8.7%
of all LAPATINIB reports
41
Deaths
21
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LAPATINIB?
Of the 173 reports, 41 (23.7%) resulted in death, 21 (12.1%) required hospitalization, and 3 (1.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAPATINIB. However, 173 reports have been filed with the FAERS database.
What Other Side Effects Does LAPATINIB Cause?
Diarrhoea (382)
Disease progression (227)
Palmar-plantar erythrodysaesthesia syndrome (182)
Nausea (161)
Metastases to central nervous system (160)
Neutropenia (160)
Vomiting (155)
Asthenia (148)
Fatigue (139)
Off label use (118)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LAPATINIB Alternatives Have Lower Malignant neoplasm progression Risk?
LAPATINIB vs LAPATINIB DITOSYLATE
LAPATINIB vs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN
LAPATINIB vs LARONIDASE
LAPATINIB vs LAROTRECTINIB
LAPATINIB vs LASILIX